GLOBAL FUND-SUPPORTED PROGRAMS IN UGANDA FACE SIGNIFICANT CHALLENGES AMID THE COVID-19 PANDEMIC AND NATIONAL ELECTIONS
ABSTRACT
It is predicted that disruptions from COVID-19, increased resource needs and changes in health focus will continue to impact on the performance and outcomes of programs for HIV, TB, malaria and other communicable and non-communicable diseases in Uganda. Contributing to the uncertainty, the election measures imposed between October 2020 and February 2021 also impacted negatively on the response to COVID-19 and other health programs.
CORRUPTION, FRAUD AND DISINFORMATION DURING THE CORONAVIRUS DISEASE 2019: HEIGHTENED VIGILANCE IS NECESSARY
ABSTRACT
International donors, including the Global Fund to Fight AIDS, Tuberculosis and Malaria, promptly made funds available to assist the fight of the COVID-19 pandemic. It is important to assess whether existing mechanisms, including the Global Fund’s “three-line defense model,” can be used to manage risk in the context of the COVID-19 crisis. Allegations of fraud and corruption are multiplying across countries. Aidspan relies on civil society organizations to help maintain accountability in this COVID-19 pandemic.
AS FOR HIV PANDEMIC, TRUCK DRIVERS AT HIGH RISK OF CONTRACTING AND TRANSMITTING COVID-19 IN EAST AFRICA
ABSTRACT
Truck drivers who transport cargo across borders in the East African Community partners are at high risk of contracting and transmitting the COVID-19. The truck drivers are also at a higher risk of HIV infection.
Global Fund Country Coordinating Mechanism evolution initiative: Mid-term lessons from Tanzania, Niger, Uganda and Burundi
ABSTRACT
The Country Coordinating Mechanism evolution initiative is at mid-point. Information from four African countries suggests mixed results: two countries with early signs of success and two where it is too early to measure success, country representatives say. Aidspan’s policy team highlights the challenges and keys to success discussed with representatives from each of the four countries featured in this article.
Three countries, three different applications of co-financing in Global Fund grants in sub-Saharan Africa
ABSTRACT
Kenya, Uganda and Guinea are three African countries at different levels of economic development, and with different epidemiology for the HIV, tuberculosis and malaria. The application of co-financing within their programming for the three diseases differs largely by country. It is important that the Secretariat harmonizes the application of the policy across countries despite the need for customization.
Global Fund multi-country program in East Africa spearheads trip to China to learn about harm reduction technologies
ABSTRACT
A delegation of East Africans visited harm reduction facilities in China to learn about their approach take-home methadone for people who use drugs, for possible application at home. The exchange was organized via the Global Fund’s multi-country harm reduction grant in East Africa, which is coming to an end this year.
TRP PRAISES UGANDA’S TB/HIV FUNDING REQUEST TO THE GLOBAL FUND, BUT SENDS TWO MATCHING FUNDS REQUESTS BACK FOR ITERATION
ABSTRACT
In recommending Uganda's funding request for TB/HIV, the Technical Review Panel particularly praised efforts to improve sustainability and the inclusion of interventions aimed at removing structural and legal barriers to key and vulnerable populations accessing services. The funding request is heavily weighted toward HIV.
UGANDA CONTINUES TO GRAPPLE WITH THE CHALLENGE OF EXPIRED MEDICINES AND HEALTH SUPPLIES
ABSTRACT
The problem of expired drugs and medical supplies prevails in Uganda. Following the release of the Uganda OIG report which made specific mention of the problem, media in the country have conducted surveys to investigate the issue further. This article presents the findings of journalists that visited different health facilities and reported on the prevailing issue of expired drugs.
FUNDING APPROVED FOR SHORTENED HIV GRANT TO UGANDA
ABSTRACT
The board approved additional funding of $37 million to allow a shortened HIV grant to Uganda to provide full services through to the end of 2017. The new funds will be used to purchase additional antiretrovirals.
FUND ADDRESSES SHORTAGES OF ARVS IN UGANDA
ABSTRACT
In response to a shortage of antiretrovirals in Uganda, The Global Fund arranged to procure and ship an immediate supply of the drugs. The Fund is also procuring a full year’s supply to guard against future shortages.